Ron Do, PhD
img_Ron Do
PROFESSOR | Genetics and Genomic Sciences
Research Topics
Atherosclerosis, Cardiovascular, Computational Biology, Epigenetics, Genetics, Genomics, Human Genetics and Genetic Disorders, Systems Biology
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
Do Lab Description
Please see for a description of the research performed in the Do Lab.

BSc, University of British Columbia

MSc, University of British Columbia

PhD, McGill University

Post-doc, Massachusetts General Hospital/Broad Institute/Harvard Medical School

Instructor, Harvard Medical School


The Dr. Harold and Golden Lamport Clinical Research Award

Icahn School of Medicine at Mount Sinai


Banting Fellowship

Canadian Institutes of Health Research

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Do during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • Pensieve Health


  • Pensieve Health
  • Variant Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.